Rapid Micro Biosystems Inc (RPID) support and resistance · rev $16.1M
Rapid Micro Biosystems Inc (RPID) is a medical devices company listed on NASDAQ.
This page maps Rapid Micro Biosystems Inc (RPID) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RPID revenue for 2026-06-30 was $16.1M. Net income was -$27.2M. RPID currently screens at market cap $85.7M.
RPID currently screens at market cap $85.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RPID 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RPID quote page for the session range and the stock page for the full model.
Not investment advice.